Altium Capital Management LP Mei Pharma, Inc. Transaction History

Altium Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $4.26 Million - $6.16 Million	-1,828,066 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.6 - $3.65 $3.09 Million - $4.34 Million	1,189,983 Added 186.49%	1,828,066 $5.21 Million
Q1 2021 May 06, 2021	BUY	$2.73 - $4.5 $1.74 Million - $2.87 Million	638,083 New	638,083 $2.19 Million

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.